Vor Biopharma Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $194.4M | $90.0M |
| Jun 2022 | — | $175.0M | $63.0M |
| Sep 2022 | — | $158.7M | $60.8M |
| Dec 2022 | — | $250.6M | $57.7M |
| Mar 2023 | — | $230.2M | $42.5M |
| Jun 2023 | — | $204.5M | $32.2M |
| Sep 2023 | — | $174.8M | $45.0M |
| Dec 2023 | — | $150.7M | $31.4M |
| Mar 2024 | — | $123.0M | $45.0M |
| Jun 2024 | — | $98.1M | $76.1M |
| Sep 2024 | — | $73.0M | $52.8M |
| Dec 2024 | — | $96.7M | $81.9M |
| Mar 2025 | — | $66.1M | $50.0M |
| Jun 2025 | — | $-1.51B | $190.6M |
| Sep 2025 | — | $-2.23B | $160.5M |
| Dec 2025 | — | $-164.3M | $396.5M |
| Mar 2026 | — | $-150.4M | $169.9M |
| Jun 2026 | — | $-200.2M | $107.9M |